321 related articles for article (PubMed ID: 29420224)
1. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
[TBL] [Abstract][Full Text] [Related]
2. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
Dumbrava EI; Meric-Bernstam F
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
[TBL] [Abstract][Full Text] [Related]
3. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
4. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Madhavan S; Subramaniam S; Brown TD; Chen JL
Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
Tran TH; Shah AT; Loh ML
Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
[TBL] [Abstract][Full Text] [Related]
6. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
7. Pediatric oncology enters an era of precision medicine.
Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
[TBL] [Abstract][Full Text] [Related]
8. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
9. European society for medical oncology virtual congress: Molecular analysis for precision oncology, October 9th - October 10th, 2020.
Messin LJ
EBioMedicine; 2021 Feb; 64():103219. PubMed ID: 33517074
[No Abstract] [Full Text] [Related]
10. Progress in precision therapy in pediatric oncology.
O'Donohue T; Farouk Sait S; Glade Bender J
Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Molloy MP; Engel A
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
[No Abstract] [Full Text] [Related]
12. OCTANE: Oncology Clinical Trial Annotation Engine.
Zeng J; Shufean MA; Khotskaya Y; Yang D; Kahle M; Johnson A; Holla V; Sánchez N; Mills Shaw KR; Bernstam EV; Meric-Bernstam F
JCO Clin Cancer Inform; 2019 Jul; 3():1-11. PubMed ID: 31265323
[TBL] [Abstract][Full Text] [Related]
13. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.
Shen JP; Ideker T
J Mol Biol; 2018 Sep; 430(18 Pt A):2900-2912. PubMed ID: 29932943
[TBL] [Abstract][Full Text] [Related]
15. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
16. Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.
Zeng J; Johnson A; Shufean MA; Kahle M; Yang D; Woodman SE; Vu T; Moorthy S; Holla V; Meric-Bernstam F
JCO Clin Cancer Inform; 2019 Sep; 3():1-12. PubMed ID: 31550176
[TBL] [Abstract][Full Text] [Related]
17. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
18. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
Doble B
Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
[TBL] [Abstract][Full Text] [Related]
19. Precision oncology: a clinical and patient perspective.
Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
[TBL] [Abstract][Full Text] [Related]
20. Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A; Moscow JA
Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]